Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eleven Biotherapeutics Inc (NASDAQ:EBIO)

1.30
Delayed Data
As of Oct 20
 +0.01 / +0.78%
Today’s Change
0.90
Today|||52-Week Range
3.23
-31.94%
Year-to-Date
No recent news for Eleven Biotherapeutics Inc.

Today’s Trading

Previous close1.29
Today’s open1.41
Day’s range1.25 - 1.41
Volume98,440
Average volume (3 months)260,271
Market cap$32.1M
Dividend yield--
Data as of 3:58pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-2,155.56%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+2,928.38%
P/E ratio5.0
Price/Sales1.38
Price/Book0.82

Competitors

 Today’s
change
Today’s
% change
VICLVical Inc0.000.00%
NVUSNovus Therapeutics I...-0.09-1.97%
JAGXJaguar Health Inc+0.00+1.08%
ITEKInotek Pharmaceutica...+0.05+2.15%
Data as of 3:59pm ET, 10/20/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$30.0M
Annual profit (last year)$1.9M
Net profit margin6.31%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen Allen Hurly
Chief Financial Officer
Richard F. Fitzgerald
Corporate headquarters
Cambridge, Massachusetts

Forecasts